Finally, we examined the therapeutic effect of human IL-34 + IL-4 Mf in a liver fibrosis model using immunodeficient NSG mice in which human PBMCs had been administered (see the Methods section). The gene discussed is IL4; the disease is Hepatic fibrosis.